Suppr超能文献

微创冠状动脉血运重建:过去、现在与未来。

Minimal-Access Coronary Revascularization: Past, Present, and Future.

作者信息

Purmessur Rushmi, Wijesena Tharushi, Ali Jason

机构信息

Department of Cardiothoracic Surgery, Royal Papworth Hospital NHS Foundation Trust, Cambridge CB2 0AY, UK.

出版信息

J Cardiovasc Dev Dis. 2023 Jul 31;10(8):326. doi: 10.3390/jcdd10080326.

Abstract

Minimal-access cardiac surgery appears to be the future. It is increasingly desired by cardiologists and demanded by patients who perceive superiority. Minimal-access coronary artery revascularisation has been increasingly adopted throughout the world. Here, we review the history of minimal-access coronary revascularization and see that it is almost as old as the history of cardiac surgery. Modern minimal-access coronary revascularization takes a variety of forms-namely minimal-access direct coronary artery bypass grafting (MIDCAB), hybrid coronary revascularisation (HCR), and totally endoscopic coronary artery bypass grafting (TECAB). It is noteworthy that there is significant variation in the nomenclature and approaches for minimal-access coronary surgery, and this truly presents a challenge for comparing the different methods. However, these approaches are increasing in frequency, and proponents demonstrate clear advantages for their patients. The challenge that remains, as for all areas of surgery, is demonstrating the superiority of these techniques over tried and tested open techniques, which is very difficult. There is a paucity of randomised controlled trials to help answer this question, and the future of minimal-access coronary revascularisation, to some extent, is dependent on such trials. Thankfully, some are underway, and the results are eagerly anticipated.

摘要

微创心脏手术似乎是未来的发展方向。心脏病专家越来越渴望采用这种手术方式,而患者也因其优势而纷纷要求进行此类手术。微创冠状动脉血运重建术在全球范围内的应用越来越广泛。在此,我们回顾一下微创冠状动脉血运重建术的历史,会发现它几乎与心脏手术的历史一样悠久。现代微创冠状动脉血运重建术有多种形式,即微创直接冠状动脉旁路移植术(MIDCAB)、杂交冠状动脉血运重建术(HCR)和完全内镜下冠状动脉旁路移植术(TECAB)。值得注意的是,微创冠状动脉手术的命名和方法存在很大差异,这确实给比较不同方法带来了挑战。然而,这些手术方式的应用频率正在增加,其支持者也证明了这些方法对患者具有明显优势。与所有外科领域一样,目前仍然面临的挑战是证明这些技术优于经过实践检验的传统开放技术,而这非常困难。目前缺乏足够的随机对照试验来帮助回答这个问题,微创冠状动脉血运重建术的未来在一定程度上取决于此类试验。幸运的是,一些相关试验正在进行中,人们急切期待着结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b6/10455416/719e624e5528/jcdd-10-00326-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验